Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
GLP-1 receptor agonists, originally developed for diabetes, show promise in breast cancer research through metabolic pathway modulation, according to a June 2026 analysis. This potential links obesity-related risk factors to ... Read More
Continuous Coverage
Who: Hedwig and the Angry Inch screens at Rooftop Cinema Club South Beach. What: A Pride-season event celebrating…
Junior guard Jamal Boroff’s 38-point eruption in Troy’s 89-82 upset of LSU has redefined the program’s season, blending…
The Mazda MX-5 has secured the 2026 CarExpert Choice award for Best Affordable Sports Car, proving that mechanical…
Canada’s federal government on June 4, 2026, unveiled a $4.3 billion national AI strategy—dubbed “AI for All”—targeting 20%…
The first time Liam Hartman’s parents saw their son’s skin turn the color of a zebra’s stripes, they…
Researchers have developed a synthetic biomolecule that targets and degrades proteins linked to neurodegenerative diseases, offering a potential…
Global Affairs
The U.S. House of Representatives has passed a resolution to restrict President Donald Trump’s military authority regarding Iran,…
Markets And Money
Bitcoin (BTC) hit its lowest intraday price since November 2022—$61,200—as of Monday’s trading, a 3.8% decline from Friday’s…
Digital Culture
MSI’s 2026 Computex Dominance: A Deep Dive into Hardware Innovation and Ecosystem Implications At Computex 2026, MSI unleashed…
Science And Wellbeing
Recent investigations into human metabolic behavior suggest that subtle, non-dietary modifications in eating patterns—specifically the pace and mindfulness…
Screen And Sound
Shirley Foster, the woman who discovered the body of Sophie Toscan du Plantier in West Cork in 1996,…
Fixtures And Form
Jakub Mensik’s public acknowledgment of his brother Lukas as a source of inspiration underscores a deeper narrative of…
